155 related articles for article (PubMed ID: 38143299)
1. Discussion of uncertainties and the impact of different neutron RBEs on all solid cancer radiation incidence risks obtained from the Japanese A-bomb survivor data.
Hafner L; Walsh L; Rühm W
Ann ICRP; 2023 Mar; 52(1-2):17-22. PubMed ID: 38143299
[TBL] [Abstract][Full Text] [Related]
2. Assessing the impact of neutron relative biological effectiveness on all solid cancer mortality risks in the Japanese atomic bomb survivors.
Hafner L; Walsh L; Rühm W
Int J Radiat Biol; 2024; 100(1):61-71. PubMed ID: 37772764
[TBL] [Abstract][Full Text] [Related]
3. Assessing the impact of different neutron RBEs on the all solid cancer radiation risks obtained from the Japanese A-bomb survivors data.
Hafner L; Walsh L; Rühm W
Int J Radiat Biol; 2023; 99(4):629-643. PubMed ID: 36154910
[TBL] [Abstract][Full Text] [Related]
4. Neutron relative biological effectiveness for solid cancer incidence in the Japanese A-bomb survivors: an analysis considering the degree of independent effects from γ-ray and neutron absorbed doses with hierarchical partitioning.
Walsh L
Radiat Environ Biophys; 2013 Mar; 52(1):29-36. PubMed ID: 23161400
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Relative Biological Effectiveness of Neutrons across Organs of Varying Depth among the Atomic Bomb Survivors.
Cordova KA; Cullings HM
Radiat Res; 2019 Aug; 192(4):380-387. PubMed ID: 31390313
[TBL] [Abstract][Full Text] [Related]
6. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
Sasaki MS; Endo S; Hoshi M; Nomura T
J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
[TBL] [Abstract][Full Text] [Related]
7. Accounting for neutron exposure in the Japanese atomic bomb survivors.
Cullings HM; Pierce DA; Kellerer AM
Radiat Res; 2014 Dec; 182(6):587-98. PubMed ID: 25409123
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.
Schneider U; Walsh L
Radiat Environ Biophys; 2008 Apr; 47(2):253-63. PubMed ID: 18157543
[TBL] [Abstract][Full Text] [Related]
9. Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors.
Kellerer AM; Rühm W; Walsh L
Health Phys; 2006 Jun; 90(6):554-64. PubMed ID: 16691103
[TBL] [Abstract][Full Text] [Related]
10. Cancer incidence risks above and below 1 Gy for radiation protection in space.
Hafner L; Walsh L; Schneider U
Life Sci Space Res (Amst); 2021 Feb; 28():41-56. PubMed ID: 33612179
[TBL] [Abstract][Full Text] [Related]
11. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
Hunter N; Charles MW
J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
[TBL] [Abstract][Full Text] [Related]
12. Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima.
Kellerer AM; Nekolla E
Radiat Environ Biophys; 1997 Jun; 36(2):73-83. PubMed ID: 9271794
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk estimates for gamma-rays with regard to organ-specific doses Part II: site-specific solid cancers.
Walsh L; Rühm W; Kellerer AM
Radiat Environ Biophys; 2004 Dec; 43(4):225-31. PubMed ID: 15645312
[TBL] [Abstract][Full Text] [Related]
14. Risk coefficient for gamma-rays with regard to solid cancer.
Kellerer AM; Walsh L; Nekolla EA
Radiat Environ Biophys; 2002 Jun; 41(2):113-23. PubMed ID: 12201054
[TBL] [Abstract][Full Text] [Related]
15. Evidence of a neutron RBE of 70 (+/- 50) for solid-tumor induction at Hiroshima and Nagasaki and its implications for assessing the effective neutron quality factor.
Zaider M
Health Phys; 1991 Nov; 61(5):631-6. PubMed ID: 1752746
[TBL] [Abstract][Full Text] [Related]
16. Lifetime Mortality Risk from Cancer and Circulatory Disease Predicted from the Japanese Atomic Bomb Survivor Life Span Study Data Taking Account of Dose Measurement Error.
Little MP; Pawel D; Misumi M; Hamada N; Cullings HM; Wakeford R; Ozasa K
Radiat Res; 2020 Sep; 194(3):259-276. PubMed ID: 32942303
[TBL] [Abstract][Full Text] [Related]
17. Comparison of All Solid Cancer Mortality and Incidence Dose-Response in the Life Span Study of Atomic Bomb Survivors, 1958-2009.
Brenner AV; Preston DL; Sakata R; Cologne J; Sugiyama H; Utada M; Cahoon EK; Grant E; Mabuchi K; Ozasa K
Radiat Res; 2022 May; 197(5):491-508. PubMed ID: 35213725
[TBL] [Abstract][Full Text] [Related]
18. The risk of non-melanoma skin cancer incidence in the Japanese atomic bomb survivors.
Little MP; Charles MW
Int J Radiat Biol; 1997 May; 71(5):589-602. PubMed ID: 9191904
[TBL] [Abstract][Full Text] [Related]
19. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
20. Derivation of low-dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors.
Little MP; Muirhead CR
Int J Radiat Biol; 2000 Jul; 76(7):939-53. PubMed ID: 10923618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
